Drasković B, Cvejanov M
Klinika za decju hirurgiju, Medicinski fakultet, Novi Sad, Institut za zastitu zdravlja dece i omladine.
Med Pregl. 1998 Jan-Feb;51(1-2):68-72.
Propofol has proven to be a reliable anaesthetic that can be used for both induction and maintenance purposes in most common surgical procedures, either in standard anaesthetic practice or as part of total intravenous anaesthesia (TIVA).
Twenty healthy (ASAI) paediatric patients scheduled for elective minor abdominal or urology surgery were studied. Patients aged 7-16 years, weighing 25-64 kg, were premedicated with midazolam 0.1mg/kg and atropine 0.01mg/kg intramuscularly, 30 minutes before surgery. Induction dose of propofol for all patients was 2.5 mg/kg. Anaesthesia was maintained with an infusion of propofol 10 to 15 mg/kg/h. Fentanyl was injected 1-2 micrograms/kg 1 minute before the start of the infusion of propofol, just before the surgery and during the surgery if necessary. Pulse, blood pressure, respiratory rate, tidal volume, ETCO2, and O2 saturation were continuously recorded before, during and after the anaesthesia. Recovery scores were assessed with the Steward scoring system 3, 5, 15, 30, after the end of anaesthetic infusion. Blood was sampled 2 and 15 minutes after the induction, 5, 15 and 30 minutes after the end of propofol infusion.
There were no significant differences in age, weight, sort and length of the operations. After the induction spontaneous movements were registered in 35% of the patients, apnea in 25% and decrease in blood pressure in all patients. Maintenance was generally uneventful and there were no excitatory or other adverse effects. Blood concentration of propofol was followed during the anaesthesia and recovery period. Blood propofol concentration at which responses to surgery were not present were from 3.4 micrograms/ml to 4.5 micrograms/ml. Recovery was rapid and complete. All patients reached maximum value of Steward scoring system within the first 15 minutes. In the moment when patients open to command (7.2 +/- 3.2 min) average blood concentration was 1.9 micrograms/ml and when they were orientated (13.1 +/- 2.1 min) 1.3 micrograms/ml. Postoperative nausea and vomiting were not registered.
This study shows that propofol provides satisfactory, stabile anaesthesia for children with rapid and complete recovery. Children may need larger doses of propofol for induction and maintenance of anaesthesia. Results from literature suggest that propofol is metabolised faster in children than in adults (9). The incidence of side effects was low. Large vein of the forearm or antecubital fossa were used for injection of propofol and there was no pain during administration the drug. Induction dose was given slowly (over 40 seconds) and apnea was relatively rare (25%). Decreases in arterial pressures from baseline levels are known to occur with propofol but in this study it was less than in others. We find a relatively high incidence of spontaneous movements during induction (35%). Nausea and vomiting were not recorded. A continuous infusion of propofol, as described here, effectively produced stable anaesthesia without use of inhalation agents. It must be remembered that propofol possesses only hypnotic properties and additional analgesia is necessary, fentanyl is a satisfactory agent in this respect. We found that average blood propofol levels of 3.5 +/- 0.9 micrograms/ml were necessary to prevent autonomic responses during this sort of surgery. Suggested hypnotic blood levels of propofol in literature are from 2.5 to 6 micrograms/ml (5). The usual endpoints of anaesthesia (eye opening and orientation) have been measured by several authors and found to occur at concentrations of the ranges of 1.0 to 2.9 micrograms/ml and 0.6 to 1.8 g/ml, respectively.
Due to greater ease of control in regard to anesthetic depth and more rapid recovery, propofol is superior to other intravenous hypnotics for maintenance of anaesthesia.
丙泊酚已被证明是一种可靠的麻醉剂,在大多数常见外科手术的诱导和维持阶段均可使用,无论是在标准麻醉实践中,还是作为全静脉麻醉(TIVA)的一部分。
研究对象为20例计划接受择期小型腹部或泌尿外科手术的健康(ASA I级)儿科患者。患者年龄7 - 16岁,体重25 - 64 kg,于手术前30分钟肌肉注射咪达唑仑0.1mg/kg和阿托品0.01mg/kg进行术前用药。所有患者丙泊酚诱导剂量为2.5mg/kg。麻醉维持采用丙泊酚10至15mg/kg/h持续输注。在丙泊酚输注开始前1分钟、手术即将开始时及必要时在手术过程中静脉注射芬太尼1 - 2微克/千克。在麻醉前、麻醉期间及麻醉后持续记录脉搏、血压、呼吸频率、潮气量、呼气末二氧化碳分压(ETCO2)和氧饱和度。在麻醉输注结束后3、5、15、30分钟,采用Steward评分系统评估苏醒评分。在诱导后2分钟和15分钟、丙泊酚输注结束后5分钟、15分钟和30分钟采集血样。
患者的年龄、体重、手术类型和手术时长无显著差异。诱导后,35%的患者出现自主运动,25%的患者出现呼吸暂停,所有患者均出现血压下降。麻醉维持总体平稳,未出现兴奋或其他不良反应。在麻醉和苏醒期监测丙泊酚血药浓度。对手术无反应时的丙泊酚血药浓度为3.4微克/毫升至4.5微克/毫升。苏醒迅速且完全。所有患者在最初15分钟内达到Steward评分系统的最大值。患者能对指令做出反应时(7.2±3.2分钟)平均血药浓度为1.9微克/毫升,定向时(13.1±2.1分钟)为1.3微克/毫升。未记录到术后恶心和呕吐。
本研究表明,丙泊酚可为儿童提供满意、稳定的麻醉,苏醒迅速且完全。儿童在麻醉诱导和维持时可能需要更大剂量的丙泊酚。文献结果表明,丙泊酚在儿童体内的代谢速度比成人快(9)。副作用发生率较低。采用前臂大静脉或肘前窝注射丙泊酚,给药过程中无疼痛。诱导剂量缓慢给予(超过40秒),呼吸暂停相对少见(25%)。已知丙泊酚会使动脉压从基线水平下降,但在本研究中下降幅度小于其他研究。我们发现诱导期自主运动发生率相对较高(35%)。未记录到恶心和呕吐。如本文所述,持续输注丙泊酚可有效产生稳定麻醉,无需使用吸入麻醉剂。必须记住,丙泊酚仅具有催眠作用,需要额外给予镇痛,在这方面芬太尼是一种满意的药物。我们发现,在此类手术中,平均丙泊酚血药浓度为3.5±0.9微克/毫升才能预防自主反应。文献中建议的丙泊酚催眠血药浓度为2.5至6微克/毫升(5)。几位作者测量了麻醉的常用终点指标(睁眼和定向),发现分别在血药浓度1.0至2.9微克/毫升和0.6至1.8微克/毫升范围内出现。
由于在麻醉深度控制方面更易于操作且苏醒更快,丙泊酚在麻醉维持方面优于其他静脉催眠药。